| Bioactivity | Reglitazar is an agonist for peroxisome proliferator-activated receptor α and β (PPAR α and PPAR β), which enhances insulin sensitivity, lowers blood glucose and regulates blood lipid levels[1]. |
| CAS | 170861-63-9 |
| Formula | C22H20N2O5 |
| Molar Mass | 392.40 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Ivanov K L, et al., Reductive Knoevenagel Condensation with the Zn–AcOH System[J]. Synthesis, 2021, 53(07): 1285-1291. |
Reglitazar
CAS: 170861-63-9 F: C22H20N2O5 W: 392.40
Reglitazar is an agonist for peroxisome proliferator-activated receptor α and β (PPAR α and PPAR β), which enhances
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.